Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (22.595)

31

Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study) : a French multicenter randomized phase III study

enthalten in: Journal of neurosurgery | 2024

von Picart, T. | Pallud, J. | Berthiller, J. | +33

32

Long-term efficacy and safety of adjunctive perampanel in patients from the Asia-Pacific region with refractory focal-onset seizures in Study 335 open-label extension

enthalten in: Epilepsia open | 2024

von Nishida, T. | Lee, S. | Inoue, Y. | +5

33

FDA Approval Summary : Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Woods, A. | Norsworthy, K. | Wang, X. | +9

34

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27

35

PRESTO : A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Aggarwal, R. | Heller, G. | Hillman, D. | +70

CommentIn: Nat Rev Urol. 2024 Mar;21(3):126. - PMID 38355924

36

Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B) : 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial

enthalten in: The Lancet. Haematology | 2024

von Coppens, M. | Pipe, S. | Miesbach, W. | +36

37

Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause : effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2)

enthalten in: Menopause (New York, N.Y.) | 2024

von Santoro, N. | Nappi, R. | Neal-Perry, G. | +4

38

Intravesical Interferon Therapy vs Hyaluronic Acid for Pain Among Female Individuals With Interstitial Cystitis : A Randomized Clinical Trial

enthalten in: JAMA network open | 2024

von Shen, S. | Peng, L. | Zeng, X. | +3

39

Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011) : A Phase 3, Randomized, Double-Blind Trial

enthalten in: European urology | 2024

von Matsubara, N. | de Wit, R. | Balar, A. | +18

40

A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)

enthalten in: Human vaccines & immunotherapeutics | 2024

von Maestri, A. | Park, S. | Fernandes, F. | +14